J Zhu, M Wang, Y Yu, H Qi, K Han, J Tang… - …, 2014 - pmc.ncbi.nlm.nih.gov
Recent clinical trials have demonstrated targeting PI3K pathway is a promising strategy for
the treatment of blood cancers. To identify novel PI3K inhibitors, we performed a high …